MCM
IART icon

MV Capital Management’s Integra LifeSciences IART Stock Holding History

MV Capital Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-35
Closed -$770 – 1098
2025
Q1 		$770 Sell
35
-14
-29% -$329 ﹤0.01% 779
2024
Q4 		$1.11K Buy
49
+34
+227% +$742 ﹤0.01% 742
2024
Q3 		$273 Buy
15
+12
+400% +$278 ﹤0.01% 870
2024
Q2 		$88 Buy
+3
New +$89 ﹤0.01% 906
2024
Q1 		– Sell
-2
Closed -$88 – 865
2023
Q4 		$88 Buy
+2
New +$79 ﹤0.01% 726

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

MV Capital Management's IART Position: Q2 2025 in Review

MV Capital Management sold out of Integra LifeSciences (IART) in Q2 2025, closing a stake of 35 shares — an estimated $770 sold.

MV Capital Management first reported a position in IART in Q4 2023 and held it in 5 quarters. The position peaked at $1.11K in Q4 2024. 208 funds tracked by Wall St. Rank hold IART as of Q2 2025.

  • MV Capital Management reported no remaining Integra LifeSciences position as of Q2 2025 after selling out during the quarter.
  • MV Capital Management sold 35 Integra LifeSciences shares in Q2 2025, an estimated $770.
  • MV Capital Management first reported a position in Integra LifeSciences in Q4 2023 and held it in 5 quarters.
  • MV Capital Management's Integra LifeSciences position peaked at $1.11K in Q4 2024.
  • 208 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2025.

Based on MV Capital Management's 13F filing for Q2 2025, filed 8 Aug 2025.